SCHEMBL13076545

SCHEMBL13076545

CN(CCN)S(=O)(=O)c1ccc2nc(C(=O)c3ccc(N)c(-c4cncc5ccccc45)c3)[nH]c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 4/20 0.44
CCND1 P24385 4/20 0.44
CCND3 P30281 4/20 0.44
CDK6 Q00534 4/20 0.44
CCNA2 P20248 3/20 0.44
CDK2 P24941 3/20 0.44
CCNA1 P78396 3/20 0.44
CDK1 P06493 3/20 0.44
CCNB1 P14635 3/20 0.44
RET P07949 2/20 0.38
CHEK2 O96017 1/20 0.38
MMP9 P14780 2/20 0.34
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
MAPK10 P53779 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ABL1 P00519 2/20 0.32
FABP6 P51161 1/20 0.32
MMP1 P03956 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111248 0.90 CDK4 (0.52) CDK4CCND1CCND3CDK6CCNA2
SCHEMBL3720082 0.74 CDK4 (0.55) CDK4CCND1CCND3CDK6CCNA2
SCHEMBL13076543 0.69 CDK4 (0.64) CDK4CCND1CCND3CDK6CCNA2
SCHEMBL13076292 0.67 CDK4 (0.48) CDK4CCND1CCND3CDK6CCNA2
SCHEMBL115091 0.67 CDK4 (0.65) CDK4CCND1CCND3CDK6CCNA2
SCHEMBL111500 0.66 CDK4 (0.77) CDK4CCND1CCND3CDK6CCNA2
SCHEMBL2142391 0.65 CDK4 (0.64) CDK4CCND1CCND3CDK6CCNA2
SCHEMBL175564 0.65 CDK4 (0.60) CDK4CCND1CCND3CDK6CCNA2
SCHEMBL13076260 0.65 CYP17A1 (0.46) MMP9KDM4EMAPTHSD17B10MMP1
SCHEMBL112881 0.65 CDK4 (0.74) CDK4CCND1CCND3CDK6CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010125402-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES NOVARTIS AG (CH) 2010-11-04 WO disclosed